PharmGen Science, Inc. (KRX:004720)
South Korea
· Delayed Price · Currency is KRW 3,620.00
+60.00 (1.69%)
Mar 10, 2026, 9:50 AM KST
PharmGen Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 78,009 | 74,179 | 111,355 | 105,470 | 159,511 | 165,783 | Upgrade
|
| Market Cap Growth | -0.45% | -33.39% | 5.58% | -33.88% | -3.78% | 123.51% | Upgrade
|
| Enterprise Value | 83,355 | 78,578 | 127,335 | 126,753 | 178,736 | 154,760 | Upgrade
|
| Last Close Price | 3560.00 | 4090.00 | 6200.00 | 6680.00 | 10500.00 | 11300.00 | Upgrade
|
| PE Ratio | 662.50 | 26.58 | 18.29 | 1.51 | 4.91 | 17.98 | Upgrade
|
| PS Ratio | 0.45 | 0.43 | 0.67 | 0.70 | 1.45 | 1.72 | Upgrade
|
| PB Ratio | 0.31 | 0.30 | 0.48 | 0.51 | 1.26 | 1.98 | Upgrade
|
| P/TBV Ratio | 0.31 | 0.30 | 0.48 | 0.51 | 1.26 | 1.99 | Upgrade
|
| P/FCF Ratio | - | 50.61 | 35.09 | - | - | - | Upgrade
|
| P/OCF Ratio | - | 31.11 | 20.47 | - | 20.49 | 61.96 | Upgrade
|
| EV/Sales Ratio | 0.49 | 0.46 | 0.76 | 0.84 | 1.63 | 1.60 | Upgrade
|
| EV/EBITDA Ratio | 12.03 | 5.15 | 9.52 | 11.76 | - | 146.36 | Upgrade
|
| EV/EBIT Ratio | 36.19 | 7.40 | 13.95 | 17.10 | - | - | Upgrade
|
| EV/FCF Ratio | -42.97 | 53.62 | 40.13 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.16 | 0.16 | 0.19 | 0.38 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 1.36 | 2.55 | 2.84 | 3.66 | - | 20.24 | Upgrade
|
| Debt / FCF Ratio | - | 26.60 | 11.96 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.02 | 0.00 | 0.00 | 0.10 | 0.11 | -0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.37 | 0.04 | 0.04 | 1.82 | -7.70 | -8.55 | Upgrade
|
| Net Debt / FCF Ratio | -2.75 | 0.37 | 0.17 | -1.75 | -0.60 | 5.44 | Upgrade
|
| Asset Turnover | 0.50 | 0.49 | 0.51 | 0.56 | 0.62 | 0.82 | Upgrade
|
| Inventory Turnover | 2.28 | 2.41 | 3.32 | 3.87 | 3.11 | 2.85 | Upgrade
|
| Quick Ratio | 1.26 | 1.19 | 1.16 | 0.70 | 0.76 | 1.38 | Upgrade
|
| Current Ratio | 2.08 | 1.69 | 1.51 | 1.03 | 1.09 | 1.99 | Upgrade
|
| Return on Equity (ROE) | 0.05% | 1.16% | 2.77% | 41.95% | 30.80% | 13.05% | Upgrade
|
| Return on Assets (ROA) | 1.76% | 1.88% | 1.73% | 1.72% | -1.73% | -1.01% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.83% | 4.40% | 2.86% | 3.14% | -3.55% | -2.30% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.30% | 3.60% | 3.30% | 3.00% | -3.30% | -1.90% | Upgrade
|
| Earnings Yield | 0.15% | 3.76% | 5.47% | 66.43% | 20.35% | 5.56% | Upgrade
|
| FCF Yield | -2.49% | 1.98% | 2.85% | -10.63% | -14.40% | -1.00% | Upgrade
|
| Buyback Yield / Dilution | -0.11% | -4.74% | 3.68% | -16.09% | -23.81% | -30.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.